These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15928832)

  • 41. Histamine H3-receptor isoforms.
    Bakker RA
    Inflamm Res; 2004 Oct; 53(10):509-16. PubMed ID: 15597144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
    Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
    Labeeuw O; Levoin N; Poupardin-Olivier O; Calmels T; Ligneau X; Berrebi-Bertrand I; Robert P; Lecomte JM; Schwartz JC; Capet M
    Bioorg Med Chem Lett; 2013 May; 23(9):2548-54. PubMed ID: 23535326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists.
    Cowart M; Faghih R; Gfesser G; Curtis M; Sun M; Zhao C; Bennani Y; Wetter J; Marsh K; Miller TR; Krueger K; Pan JB; Drescher K; Fox GB; Esbenshade TA; Hancock AA
    Inflamm Res; 2005 Apr; 54 Suppl 1():S25-6. PubMed ID: 15928820
    [No Abstract]   [Full Text] [Related]  

  • 47. H3 receptor ligands: new imidazole H3-antagonists endowed with NO-donor properties.
    Bertinaria M
    Farmaco; 2003 Mar; 58(3):279-83. PubMed ID: 12620423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.
    Lipani L; Odadzic D; Weizel L; Schwed JS; Sadek B; Stark H
    Eur J Med Chem; 2014 Oct; 86():578-88. PubMed ID: 25218907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Covalent Inhibition of the Histamine H
    Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
    Zhao C; Sun M; Bennani YL; Gopalakrishnan SM; Witte DG; Miller TR; Krueger KM; Browman KE; Thiffault C; Wetter J; Marsh KC; Hancock AA; Esbenshade TA; Cowart MD
    J Med Chem; 2008 Sep; 51(17):5423-30. PubMed ID: 18683917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy.
    Hancock AA; Diehl MS; Fey TA; Bush EN; Faghih R; Miller TR; Krueger KM; Pratt JK; Cowart MD; Dickinson RW; Shapiro R; Knourek-Segel VE; Droz BA; McDowell CA; Krishna G; Brune ME; Esbenshade TA; Jacobson PB
    Inflamm Res; 2005 Apr; 54 Suppl 1():S27-9. PubMed ID: 15928821
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.
    Petroianu G; Arafat K; Sasse BC; Stark H
    Pharmazie; 2006 Mar; 61(3):179-82. PubMed ID: 16599255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Keynote review: histamine H3 receptor antagonists reach out for the clinic.
    Celanire S; Wijtmans M; Talaga P; Leurs R; de Esch IJ
    Drug Discov Today; 2005 Dec; 10(23-24):1613-27. PubMed ID: 16376822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structure-activity relationships of 2-(1,4'-bipiperidin-1'-yl)thiazolopyridine as H3 receptor antagonists.
    Rao AU; Palani A; Chen X; Huang Y; Aslanian RG; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6176-80. PubMed ID: 19773164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The future antihistamines: histamine H3 and H4 receptor ligands.
    Yu F; Bonaventure P; Thurmond RL
    Adv Exp Med Biol; 2010; 709():125-40. PubMed ID: 21618893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium binding to hH3R and hH 4R--a molecular modeling study.
    Wittmann HJ; Seifert R; Strasser A
    J Mol Model; 2014 Aug; 20(8):2394. PubMed ID: 25098339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L
    ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine H3 receptor antagonists: from target identification to drug leads.
    Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T
    Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
    Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
    Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The medicinal chemistry of novel H(3) antagonists.
    Cowart M; Faghih R; Gfesser G; Curtis M; Pratt JK; Bennani Y; Fox GB; Esbenshade TA; Hancock AA
    Inflamm Res; 2004 Mar; 53 Suppl 1():S69-70. PubMed ID: 15054624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.